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Abstract
Because of the many superficial similarities between the immune system and the central ner-
vous system, it has long been speculated that somatic DNA recombination is, like the immune
system, involved in brain development and function. To examine whether or not the V(D)J recom-
bination signals of the immune system work in an in vitro neural differentiation model, the P19
mouse embryonal carcinoma cell line was transfected with a reporter gene that is designed, when
rearranged, to express bacterial beta-galactosidase, which was previously reported to exhibit so-
matic DNA recombination in the transgenic mouse brain. The cloned cells were then induced into
neural cells by retinoic acid treatment. This neural induction treatment resulted in the cloning of a
P19 cell line that showed a high incidence of beta-galactosidase-positive cells. Most of these beta-
galactosidase-positive cells were immunocytochemically identified as either neurons, neuroepithe-
lial cells, or astrocytes. The 5’-end sequences of the beta-galactosidase transcripts expressed in the
induced cells were analyzed, and sequences were found that seemed to reflect DNA rearrangement
through re-integration of the reporter gene into the host genome. However, the V(D)J recombina-
tion signals did not work in the in vitro model. These results suggested that DNA rearrangement
activity though integration increased during neural differentiation of P19 cells.
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Because of the many superficial similarities between the immune system and the central nervous system, it has long been speculated that somatic DNA recombination is, like the immune system,
involved in brain development and function. To examine whether or not the V(D)J recombination signals of the immune system work in an  neural differentiation model, the P19 mouse embryonal carcinoma cell line was transfected with a reporter gene that is designed, when rearranged, to express bacterialβ-galactosidase, which was previously reported to exhibit somatic DNA recombination in the transgenic mouse brain. The cloned cells were then induced into neural cells by retinoic acid treatment. This neural induction treatment resulted in the cloning of a P19 cell line that showed a high incidence ofβ-galactosidase-positive cells.Most of theseβ-galactosidase-
positive cells were immunocytochemically identified as either neurons, neuroepithelial cells, or astrocytes. The 5’-end sequences of theβ-galactosidase transcripts expressed in the induced cells were analyzed, and sequences were found that seemed to reflect DNA rearrangement through re-integration of the reporter gene into the host genome. However, the V(D)J recombination signals did not work in the  model. These results suggested that DNA rearrangement activity though integration increased during neural differentiation of P19 cells.
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U nlike germ-line cells, somatic cells of multicellular organisms do not necessarily require all of a species’DNA information, as they are fated to lose their totipotency and survive for only one generation. Some exceptions to the DNA constancy rule have been report-
ed:chromatin diminution in nematodes ［1, 2］,
chromosomal elimination in ciliated protozoa［3］and ﬂies
［4, 5］, and DNA excision in lymphocytes of vertebrates
［6］. Somatic DNA recombination plays an important role in the immune system:V(D)J recombination and
 
class switching of immunoglobulin genes in lymphocytes are followed by DNA excision［7］. There are many superﬁcial similarities between the immune system and the central nervous system:extreme diversity, enormous capacity for memory, extensive developmental program-
med cell death［8, 9］, cytokines and their receptors
［10］, immunoglobulin superfamily members［11］, and proteins involved in DNA rearrangement, such as Rad51,
a homolog of Escherichia coli (E. coli)RecA［12］, and topoisomerase IIβ［13］. Because of these parallels, it has long been speculated that somatic DNA recombina-
tion is, like the immune system, involved in brain development and function［14］.
Recently, cadherin-related neuronal receptor/
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protocadherin (CNR/Pcdh)genes, which are subfamily members of the cadherin superfamily, have been shown to consist of multiple gene clusters, including multiple variable exons and several constant exons similar to the immunoglobulin and T-cell receptor gene clusters in the immune system［15］. Detailed studies have demonstrat-
ed that the diverse molecular expression of the CNR/
Pcdh genes in neurons has been achieved through the choice of an alternative promoter by each variable exon and alternative cis-splicing of the transcripts, and, at a far lower level, through trans-splicing of the transcripts［16,
17］. Rearrangement of the gene assembly DNA, such as the deletion of genomic DNA in the immune system, has not been found in the CNR/Pcdh gene clusters［16, 17］.
Matsuoka et al.reported that bacterialβ-galactosidase was expressed in lymphocytes and certain regions of the brain in transgenic mice possessing a recombination reporter gene, and speculated that this expression was a result of DNA rearrangement［18］. However, using a similar approach, Kawaichi et al. were able to detect DNA recombination in only the lymphocytes of transgenic mice［19］.
In the present study, we examined whether or not the V(D)J recombination signal of immunoglobulin works in an in vitro neural diﬀerentiation model, the P19 mouse embryonal carcinoma cell line［20］, as Matsuoka et al.
demonstrated in transgenic mice. We then analyzed the 5’-end sequences of the reporter gene transcripts express-
ed during neural diﬀerentiation.
Materials and Methods
 
The EcoRI fragment(～20kbp)of the recom-
bination reporter gene plasmid, pkZ1, kindly provided by Dr.Sakano, H.［18］, was integrated into the EcoRI site of a pSV2neo vector so that the chickenβ-actin enhancer-
promoter complex had the same transcriptional direction as the neomycin-resistant gene (Fig. 1A). Before the integration of the reporter gene, the BamHI site of the pSV2neo vector had been altered into a Not I site for the following linearization. The resulting reporter plasmid,
pRECneo, was linearized by Not I restriction enzyme digestion and separated by 0.8 agarose gel electrophore-
sis. The fragment was excised and puriﬁed using glass powders included in a FlexiPrep kit(Amersham Bioscien-
ces, Piscataway, NJ, USA).
Fifteen
μg of linearized DNA was transfected into 3×10?P19 mouse embryonal carcinoma cells(ATCC CRL 1825)by a calcium phosphate-mediated procedure as previously described［21］. G418 (Invitrogen, Carlsbad, CA,
USA)was added to the culture medium at 400μg/ml for selection of G418-resistant cells.
Genomic DNA of P19 and that of the cloned cells, P19REC09, were puriﬁed using a standard phenol-chloroform extraction
［22］. The genomic and pRECneo plasmid DNAs were digested with EcoRI and/or XbaI restriction enzyme.
Each 10μg of the digested genomic DNA and each 500 ng of the digested plasmid DNA was separated by 0.8 agarose gel electrophoresis and blotted onto a Hybond-
N＋ membrane(Amersham Biosciences)by a standard capillary method［22］. The membrane was ﬁxed with 0.4N NaOH. Hybridization was performed in 5×SSC,
0.1 (w/v)lauroylsarcosine, 0.02 (w/v)SDS, and 1 blocking agent (Roche Diagnostics, Basel, Switzer-
land)with a digoxigenin-labeled lacZ gene-speciﬁc oligonu cleotide probe(Z-10, 5’-TTCCGGCACCGCTTCTGG TGC-3’)at 45°C. The 3’end of the Z-10 oligonucleotide was labeled with digoxigenin using digoxigenin-11-ddUTP and terminal transferase (Roche Diagnostics). The hybridized membrane was washed in 0.6×SSC and 0.02 SDS at 50°C. Non-RI chemiluminescent detection with an alkaline phosphatase-conjugated anti-digoxigenin antibody and a CDP-Star chemiluminescent substrate was performed according to the manufacturer’s instruction manual(Roche Diagnostics).
P19 cells were cultured on tissue culture-grade dishes in a minimal essential medium (αMEM, Cosmo Bio,
Tokyo, Japan)supplemented with 10  fetal calf serum
(Invitrogen) at 37°C in a 5  CO? atmosphere.
Diﬀerentiation treatments were performed as described by Rudnicki et al.［20］. Brieﬂy, for aggregation (AG)
treatments, bacterial-grade culture dishes were used. For retinoic acid (RA) treatments, all-trans retinoic acid
(Sigma-Aldrich, St.Louis, MO,USA)was added to the medium at 5×10??M. For dimethyl sulfoxide(DMSO,
Sigma-Aldrich) treatments, DMSO was added to the medium at 1  v/v. For retinoic acid with aggregation
(RA＋AG)treatments, cells were cultured on bacterial-
grade culture dishes in medium containing 5×10??M RA. For dimethyl sulfoxide with aggregation(DMSO＋
AG)treatments, cells were cultured on bacterial-grade culture dishes in medium containing 1  v/v DMSO.
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Fig.1  Structure of the recombination reporter gene(A)and assumed modes of bacterialβ-galactosidase expression(B, C, D, E, F, G,
H). In the gene, the lacZ bacterialβ-galactosidase gene was oriented inverse the transcriptional direction of the chickenβ-actin enhancer-
promoter complex(βEP). The lacZ gene was ﬂanked by recombination signal sequences of the mouse immunoglobulin Vk21c and Jk5 segments.
The reporter gene was originally designed to perform a site-speciﬁc accurate inversion(B)at the recombination signal sequences. The lacZ gene, when inverted, was transcribed into pre-mRNA by transcription from theβ-actin promoter. RNA splicing signals of the actin gene exons
(βEx 1 andβEx 2)were used to remove the extra sequence surrounding the signal junction. C, Ambiguous inversion around the recombination signals. D, Integration into an intron of a certain gene expressed in the cell. E, integration into an exon of a certain gene expressed in the cell. F, Integration into a region controlled by a certain enhancer and activation of a cryptic promoter in the reporter gene. G, Integration into the vicinity of a certain promoter activated in the cell. H, Activation of a cryptic promoter in the reporter gene without a rearrangement.
χP, χE, andχEx1 indicate a promoter, an enhancer, and an exon of a certain gene in the genomes, respectively.
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As described by Sanes et al., cultured cells ﬁxed with 2  formaldehyde, 0.2 glutaraldehyde were incubated for 4-16h at 37°C in a histochemical reaction mixture containing 1mg/ml 5-
bromo-4-chloro-3-indolyl-β-D-galactoside(X-gal, Sigma-
Aldrich)［23］. β-galactosidase-positive, blue-stained cells were counted in a given area using a microscope.
Total cell counts were obtained with a hematocytometer.
Following  histo-
chemical detection, immunocytochemical staining was performed. Monoclonal antibodies to nestin(clone R401,
1:500, BD Biosciences PharMingen, San Diego, CA,
USA), neuroﬁlament 200kDa (clone NE14, 1:500,
Sigma-Aldrich), and glial ﬁbrillary acidic protein (clone G-4-A, 1:500, Roche Diagnostics)were used as primary antibodies. Biotinylated anti-mouse IgG horse serum
(Vector, Burlingame, CA, USA)was the secondary antibody. Alkaline phosphatase-conjugated streptavidin
(Vector)was used for labeling the biotinylated secondary antibodies, and 3-hydroxy-N-2’-biphenyl-2-
naphthalenecarboxamide phosphate (Roche Diagnostics)
was the alkaline phosphatase substrate.
5’RACE was perform-
ed as previously described［24］. Messenger RNA
(mRNA)was puriﬁed from 4-day RA-treated and 4-day RA＋AG-treated P19REC09 cells using a QuickPrep Micro mRNA Puriﬁcation Kit (Amersham Biosciences)
according to the manufacturer’s protocols. Contaminating genomic DNA was digested with 1 unit perμl DNase I
(Amersham Biosciences)in a reaction buﬀer containing 20 mM Tris-HCl(pH8.0), 50mM KCl, and 2mM MgCl?.
First-strand cDNA was reverse-transcribed from the mRNA with a lacZ-speciﬁc primer(Z-08, 5’-TGTAGC CAGCTTTCATCAAC-3’)and a reverse transcriptase,
SuperScript II (Invitrogen). Poly A tails were added to the cDNA with 0.5 units perμl of terminal deoxynu-
cleotidyl transferase (Toyobo, Osaka, Japan). First-
round polymerase chain reaction (PCR)was performed with an adapter primer for the poly A tail (ADE,
5’-GAGTCGACTCGAGAATTCTTTTTTTTTTTTT TTTT-3’)including an EcoRI site and an inner lacZ-
speciﬁc primer (Z-09, 5’-ATTGACCGTAATGGGAT AGG-3’)by using ExTaq thermostable DNA polymerase
(Takara Bio, Otsu, Japan)and an aliquot of the cDNA as a template under the following conditions:denaturing at 95°C, annealing at 55°C, extension at 72°C, 45
 
cycles. Second semi-nested PCR was carried out with the adapter primer (ADE) and another, more-inner lacZ-
speciﬁc primer (ZE-06, 5’-GCGAATTCTTGGTGTA GATGGGCGCATCGTAACCGTGC-3’)containing an EcoRI site, by using an aliquot of the ﬁrst PCR product as a template under the following conditions:denaturing at 95°C, annealing at 65°C, extension at 72°C, 30 cycles. The PCR products were digested with an EcoRI restriction enzyme and ligated to the EcoRI site of the
λZIPLox phage(Invitrogen). To package the integrated
λZIPLox phage DNA, GigaPack III Gold packaging extract was used according to the manufacturer’s instruc-
tions(Stratagene, La Jolla, CA, USA). The construct-
ed phage library was screened by a digoxigenin-labeled lacZ gene-speciﬁc oligonucleotide probe(Z-10,5’-TTCCGG CACCGCTTCTGGTGC-3’). Digoxigenin labeling and non-radioisotopic detection were performed according to the Southern blot analysis procedure. Sequences of positive clones were analyzed by an ABI dye terminator cycle sequencing kit and an ABI sequencer model 373
(Applied Biosystems, Foster City, CA, USA).
Results
 
We isolated 11 G418-
resistant clones out of 3×10?cells transfected with 15μg of the reporter DNA.We subjected the isolated clones to retinoic acid and aggregation treatment to induce neural cell diﬀerentiation. One clone, the P19REC09 cell, was found to have a high incidence ofβ-galactosidase-positive cells in the diﬀerentiated state (Fig. 4) according to histochemical X-gal staining［23］, while almost no
β-galactosidase-positive cells appeared in the undiﬀerentiated state(data not shown).
Genomic Southern blot analysis with a lacZ-speciﬁc probe conﬁrmed that the P19REC09 cloned cell contained a full length of the reporter gene(Fig. 2). A single～20-kbp fragment was identiﬁed on the lane of EcoRI-digested DNA(lane 1 in Fig. 2), and a single～8-kbp fragment was found on the lane of EcoRI and XbaI digestion (lane 3 in Fig. 2).
These fragments were consistent with the pRECneo reporter plasmid fragments (lanes 5 and 6 in Fig. 2,
respectively)and the expected fragment sizes(Fig. 1A).
Thus the cloned cell contained a full-length reporter gene.
The incidence of
β-galactosidase-positive cells was analyzed in the time course of induction treatments(Fig. 3). In the treatment
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 of RA without aggregation (RA)for neuroepithelial cell induction, the incidence ofβ-galactosidase-positive cells was 201.7±24.2 at day 2, 534.9±15.9 at day 4, and 149.0±8.1 at day 7(per 10?total cells, mean±SEM,
n＝5). In the treatment of RA with aggregation(RA＋
AG)for induction of neurons and glia, the incidence was 102.2±18.2 at day 2, 194.8±18.3 at day 4, and 19.2±
2.3 at day 7. There were signiﬁcant increases at all days of RA treatment and at days 2 and 4 of RA＋AG treatment vs. no induction treatment (0.8±0.05, one-
way ANOVA, P ＜ 0.05). On the other hand, there were no signiﬁcant diﬀerences at day 7 of RA＋AG treatment for the neural cell induction or at any day of the other treatments for the induction of non-neural cells:
aggregation only (AG), DMSO without aggregation
(DMSO), and DMSO with aggregation(DMSO＋AG).
Treatment by retinoic acids with or without aggregation signiﬁcantly increased the incidence ofβ-galactosidase-
positive cells.
To clarify whether
β-galactosidase-positive cells are neural cells or not,
X-gal histochemical and immunocytochemical double-
staining studies were performed(Fig. 4).Histochemically detected blue-stained β-galactosidase-positive cells in-
duced by treatment of RA(Fig. 4A and D)or RA＋AG
(Fig. 4B, C, E, F)were further stained with antibodies
 
to nestin(Fig. 4D), neuroﬁlament 200kD (Fig. 4E), or glial ﬁbrillary acidic protein(Fig. 4F);these are markers of neuroepithelial cells, neurons, and astrocytes, respec-
tively. The neural markers stained almost no β-
galactosidase-positive cells induced by the other treat-
ments (AG, DMSO, DMSO＋AG)(data not shown).
Most β-galactosidase-positive cells consisted of neuro-
epithelial cells, neurons, and astrocytes, in addition to a trace portion that was non-neural(Fig. 4B and E).
To determine the tran-
script sequence involved in the expression of bacterial
β-galactosidase activity, we analyzed the 5’ends using the 5’RACE method. As summarized in Fig. 5,
sequence analysis of 54 randomly selected clones showed 25 diﬀerent sequences of 5’ends. Of these sequences,
17, indicated by arrowheads, included the start codon of artiﬁcialβ-galactosidase from E. coli and were expected to express functional enzymes, while the other 8, indicat-
ed by open arrowheads, were from downstream of the start codon, suggesting that they failed to gain enzyme activity. Two of the 17 transcripts with the start codon
(exons 1a and 1b in Fig. 5)were found to have parts of the chickenβ-actin ﬁrst intron in the reporter gene as ﬁrst exons, using cryptic GT-AG splicing signals;2 others
(exons 1c and 1d in Fig. 5)had unknown short sequences that did not obey the GT-AG splicing rule. Of the 25
 
Fig.2  Southern blot analysis. Each 10μg of genomic DNA was separated by 0.8% agarose gel electrophoresis and blotted onto a nylon membrane. Detection was performed with a bacterial lacZ-
speciﬁc probe. Genomic DNA from the cloned P19 cell with the reporter gene was digested with EcoRI(lane 1)or EcoRI and XbaI
(lane 3). Genomic DNA from the P19 cell line without the reporter gene was also digested with EcoRI(lane 2)or EcoRI and XbaI(lane 4). The reporter gene plasmid was digested with EcoRI(lane 5)or EcoRI and XbaI(lane 6).
Fig.3  Eﬀects of diﬀerentiation treatments on the incidences of
β-galactosidase-positive cells and their time course. Abbreviations refer to treatment types. AG, aggregation;DMSO, dimethylsulfox-
ide;RA, retinoic acid;DMSO＋AG, dimethylsulfoxide with aggrega-
tion;RA＋AG, retinoic acid with aggregation. Each column repre-
sents the mean±SEM (n＝5). The asterisks denote signiﬁcant diﬀerences vs. control of undiﬀerentiated cells (P＜0.05, one-way ANOVA).
267 DNA Rearrangement during Neurogenesis December 2004
5
Kawabata et al.: DNA rearrangement activity during retinoic acid-induced neural
Produced by The Berkeley Electronic Press, 2004
 Fig.4  Immunocytochemical cell type identiﬁcation of bacterialβ-galactosidase-positive cells. Cells induced by retinoic acids(A)or retinoic acids with aggregation(B, C)were histochemically stained with X-gal. β-galactosidase-positive, blue-stained cells indicated by arrowheads
(A, B, C)were also labeled, respectively, with antibodies to nestin(D), neuroﬁlament 200 kD(E), or glial ﬁbrillary acidic protein(F). The asterisk indicates a non-neuralβ-galactosidase-positive cell(B). Scale bar, 30μm.
Fig.5  5’end sequences of bacterialβ-galactosidase mRNA expressed in the induced cells. REC represents the sequence of the reporter plasmid, pRECneo. Closed arrowheads show transcription initiation sites upstream of theβ-galactosidase start codon, and open arrowheads show the downstream sites. Numbers on the arrowheads or to the right of the arrows indicate clone numbers of the molecular species. Bases are counted as＋1 at adenine of the start codon. Exons 1a and 1b indicate extra exons at, respectively, －634 to－600 and－322 to－
314 of the reporter gene. These exons were originally part of the chickenβ-actin ﬁrst intron constructed upstream of the lacZ. Exons 1c and 1d show extra exons of unknown sequences. βIntron 1 andβExon 2 indicate the ﬁrst intron and the second exon of a chickenβ-actin gene,
respectively.
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transcripts, 20 contained one guanine residue at each 5’
end, which strongly suggested that these were not de-
rived from artiﬁcially truncated mRNAs［25］.
Discussion
 
The P19 cell is well established as an in vitro model of neural diﬀerentiation. It is known that the number of RA-induced neuroepithelial cells peaks at day 3 after RA treatment and declines by day 5;it is also known that RA＋AG-induced neurons become overwhelmed by highly proliferative, non-neural ﬁbroblast-like cells after day 5, and that RA＋AG-induced astrocytes appear after day 10［20, 26］. Thus the time course of RA and RA＋
AG-inducedβ-galactosidase-positive cells(Fig. 3)corre-
sponds with that of RA-induced neuroepithelial cells and RA＋AG-induced neurons and neuroepithelial cells,
respectively. This was conﬁrmed by immunocytochemical analysis (Fig. 4).
Analysis of the 5’-end sequences of the reporter gene transcripts revealed that DNA rearrangement through re-integration of the reporter gene into the host genomic DNA might result in the expression ofβ-galactosidase activity, but the V(D)J recombination signals of the reporter gene did not work in the P19  neuronal diﬀerentiation model, in contrast to the previous ﬁndings in transgenic mice reported by Matsuoka et al.［18］.
Because the in vivo brain contains an enormous number of neurons, the fragments rearranged at or around the V(D)
J recombination signals in the transgenic mice brain might exist as a result of DNA rearrangement that increases during brain development but is not speciﬁc to the recom-
bination signals. Assumed modes of bacterial β-
galactosidase mRNA expression are shown in Fig. 1B to H. The accurate(Fig. 1B)and ambiguous (Fig. 1C)
inversions in transgenic mice previously reported by Matsuoka et al.［18］were not detected in this study.
These inversions may not be involved in the expression of the reporter gene observed in the induced neural cells.
The 2 transcripts with unknown sequences(exons 1c and 1d in Fig. 5)may have been generated by integration in an exon of a certain gene expressed in the induced cells
(Fig. 1E), because they did not obey the GT-AG splicing rules, unlike the 2 transcripts with chicken introns(exons 1a and 1b), as shown in Fig. 5. Their sequences were too short to conﬁrm the rearranged sites in genomic DNA. Three modes(Fig. 1F, G, H)can result in the other 23 transcripts:2 transcripts with the chicken
 
introns (exons 1a and 1b in Fig. 5)and the other 21 transcribed from upstream or downstream of the start codon ofβ-galactosidase in the reporter gene, as indicat-
ed by the closed and open arrows(Fig. 5). Because the ability of enhancers to activate transcription is relatively unrelated to their position, orientation or, to a lesser degree, the distance from the target promoter［27］, and because expression of multiple transcripts has been observed, the most probable mode of expression is integration in regions controlled by an enhancer activated in the induced cells(Fig. 1F). Integration in the vicinity of a certain promoter (Fig. 1G) is less probable, as promoters need to be a limited distance from a transcrip-
tion initiation site. The mode of cryptic promoter activa-
tion in the reporter gene without rearrangement(Fig. 1H)
is also unlikely, because it needs a rare trans-acting factor that is activated only in limited populations― that is, in less than about 0.5  of neuroepithelial cells, neurons,
and astrocytes― and also causes expression of multiple transcripts from the single reporter gene. Since the Southern blot analysis showed that the cloned P19 cell contained a full-length reporter gene, we can also exclude the possibility that the lacZ gene became integrated in the vicinity of neural cell-speciﬁc gene promoters of the cloned P19 cell before the induction treatment. The 2 transcripts with unknown sequences(exons 1c and 1d in Fig. 5)in the 4th mode(Fig. 1E)indicate genomic DNA rearrange-
ments, and the other 23 clones seem to be examples of the 5th mode, indicating DNA rearrangement by one of the integrations(Fig. 1F). Finally, these many diﬀerent 5’-end sequences of the reporter gene transcripts express-
ed in neural cells suggest that the transcripts may be a result of DNA rearrangement through re-integration of the reporter gene into the host genomic DNA, and that the recombination signals for site-speciﬁc V(D)J re-
arrangement of immunoglobulin genes do not work in the neural diﬀerentiation of P19 cells. This conclusion is consistent with the ﬁnding that only a small portion of total neural cells wereβ-galactosidase-positive, because the 5’RACE analysis revealed that many transcripts did not include the translation start codon of the reporter gene. This suggested that far more transcripts not detected by the 5’RACE were expressed in the neural cells.
The mechanisms of DNA re-integration speciﬁc to neural diﬀerentiation are yet to be elucidated. DNA integration, on the other hand, is known to include generation and rejoining processes of double-strand
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breaks (DSBs). Non-homologous end joining and homologous recombinational repair are known to be involved in DSB repair［28］. Recent investigations in the immune system demonstrated that DNA repairs, espe-
cially base excision repair and homologous recombination,
play a key role in the pathway of class-switch recombina-
tion and gene conversion［29］. Non-homologous end-
joining repair is involved in the repair of DSBs generated by RAG-1 and RAG-2［7］. These observations indicate that DNA repair plays an important role in DNA re-
arrangements, such as class-switch recombination, gene conversion, and V(D)J recombination.
The ﬁndings of the present study suggest that DNA rearrangement activity as a result of integration may increase during neurogenesis, and that the V(D)J recom-
bination signal in the immune system does not work during neural diﬀerentiation. Increased activity to repair DSBs during chromatin remodeling in neurogenesis may lead to DNA rearrangement of the unstable integrated reporter gene. Further investigation of the molecular mechanisms underlying the generation and repair proc-
esses of DSBs in neurogenesis will elucidate the entity of neuronal diﬀerentiation.
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